CMTM1_v17 contributes to chemotherapy resistance and predicts poor prognosis in non-small cell lung

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:taozijian
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: CMTM1_vl7 is a member of CKLFs and is highly expressed in human testis tissues and many human tumortissues and cell lines but almost undetectable in human normal tissues.
其他文献
  Objective: To evaluate the efficacy of treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the patients of the advanced
会议
  Objective: Lung cancer is the leading cause of cancer mortality worldwide.About 30-40% of patients with lung cancer developed bone metastasis during the cou
会议
  Objective: Non small cell lung cancer (NSCLC) is one of the most aggressive types of cancer and the leading cause of cancer mortality, yet the pathologic me
会议
  Objective: To evaluate the survival of patients with small cell lung cancer and analyze the prognostic factors in these patients.Method: Clinical data were
会议
  Objective: MicroRNA plays a crucial role in development and progression of multiple malignancies.However, the mechanisms of microRNA in cancer are not total
会议
  Objective: To evaluate the clinical activity of angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib
会议
  Objective: The effects of antituberculosis treatment in patients with coexistence of lung cancer and pulmonary tuberculosis has not been known well.The aim
会议
  Objective: KRAS mutation was a poor prognostic factor in NSCLC, the patients with KRAS-MT has shorter survival than those of KRAS-WT.So it is urgentto furth
会议
  Objective: The aim of this study is to investigate the correlation of histopathologic subtypes with epidermal growth factor receptor (EGFR) mutations and 18
会议
  Objective: To explore the risk factors of brain metastasis (BM) and the role of treatment in patients with small cell lung cancer.Method: Clinical data of 2
会议